| 1986 |
ISHIB founded, with Neil B. Shulman, MD serving
as chairman of the board of trustees, Elijah Saunders, MD as
president, and W. Dallas Hall, MD as secretary and treasurer. |
| 1987 |
ISHIB establishes the Distinguished Researcher,
Distinguished Young Researcher, and Outstanding Community Service
Awards to recognize those who have advanced the knowledge base
and patient care related to hypertension and cardiovascular
disease. |
| 1988-1993 |
ISHIB office space provided through Emory University
located on Butler Street, Atlanta, Georgia. |
| 1991 |
ISHIB publishes first volume of Ethnicity &
Disease. |
| 1992 |
Appointment of James W. Reed, MD as president
of the Society. |
| May 1993 |
ISHIB conducts its first Worship Site Blood Pressure
Education Program as its healthcare professionals address church
congregations to offer blood pressure information and screenings. |
| 1993 |
ISHIB establishes the Rosa Parks Award to recognize
organizations and individuals who have made significant contributions
in reducing the morbidity and mortality rate caused by hypertension
in ethnic populations. |
| 1993 |
Purchase and opening of ISHIB's headquarters located
at 2045 Manchester Street, NE; Atlanta, Georgia. |
| 1994 |
Kermit G. Payne appointed ISHIB's executive director.
|
| 1994 |
Release of monograph publication, Emerging
Perspectives in Hypertension: Focus on the African-American
Patient. |
| 1995 |
Release of monograph publication, AII: A Target
in Hypertensive Disease in African-American Patients. |
| 1996 |
ISHIB participates in the Accupril Titration Interval
Management Evaluation (ATIME) Clinical Trial. 1996 ISHIB launches
the Calcium Antagonists in Blacks Clinical Trial. |
| 1996 |
ISHIB conducts the seminar series: Summit on the
Use of ACE Inhibitors in African-American Hypertensives. |
| 1997 |
Release of monograph publication, Meet the
Experts: Effective Use of Combination Drug Therapy in the Treatment
of Minority Hypertensive Populations. |
| 1997 |
Release of monograph publication, The Effective
Use of Calcium Antagonists. |
| 1998 |
ISHIB participates in the TevetenŽ Clinical Trial. |
| 1998 |
Release of monograph publication, Expert Panel:
On the Effective Use of Low-Dose Combination Therapy in African-American
Patients. |
| 1998 |
ISHIB conducts the seminar series: The Role of
Renin-Angiotensin Aldosterone Systems in Hypertension and Target
Organ Injury in African Americans. |
| 1999 |
ISHIB participates in the newly organized consortium
announced by US Surgeon General David Satcher, " The Hypertension
and Cardiovascular Disease Initiative for African Americans:
Eliminating Health Disparities." The consortium is a collaborative
effort among health associations, health industry leaders, and
local communities. |
| 2000 |
ISHIB conducts the seminar series: Cardiovascular
Disease: A Unified Model - Treating the Urban Ethnic Patient |
| 2003 |
ISHIB releases Landmark Guidelines to Raise
Bar for Treatment of African Americans with High Blood Pressure
|
| 2003 |
ISHIB Board of Trustees appoints Christopher
T. Fitzpatrick as new Chief Executive Officer |
| 2004 |
ISHIB moves to the Historic Herndon Plaza in Atlanta. This
building is named for Alonzo Herndon, an ex-slave who went on
to found the Atlanta Life Insurance Company and became Atlanta's
first African-American millionaire. |
| 2004 |
ISHIB Board of Trustees appoints new President, Charles L.
Curry, MD; Secretary/Treasurer, Shawna D. Nesbitt, MD; new board
members: Clarence E. Grim, MD; Sandra Harris-Hooker, PhD; and
Keith C. Norris, MD. |
| 2005 |
ISHIB Appoints Kenneth Jamerson, MD, as Vice President; elects new board members: Brent M. Egan, MD; James A. Gavin, III, MD, PhD; David S. Kountz, MD; and Janice P. Lea, MD. |
